Chemycal has been acquired by 3E
Learn MoreDiscover how Chemycal PRO helps you boosting your regulatory monitoring:
Key findings include:
(*) Two third of respondents consider the level of protection from EDCs by EU regulations is insufficient for different groups of the population and in particular, 66% of respondents consider protection to be insufficient for the unborn child and exposure during pregnancy
(*) 53% said a category for suspected endocrine disruptors should be introduced into legislation – this would be coherent with current approaches to rank other chemicals, for example how cancer-causing chemicals are classified.
(*) 93% of respondents consider the absence of harmonised criteria to identify endocrine disruptors an important problem, leading to incoherent identification across sectors. Furthermore
(*) 73% of respondents indicated they are aware of inconsistencies and gaps in the way EDCs are identified and controlled in the European Union.
(*) 53% said a category for suspected endocrine disruptors should be introduced into legislation – this would be coherent with current approaches to rank other chemicals, for example how cancer-causing chemicals are classified.
(*) 93% of respondents consider the absence of harmonised criteria to identify endocrine disruptors an important problem, leading to incoherent identification across sectors. Furthermore
(*) 73% of respondents indicated they are aware of inconsistencies and gaps in the way EDCs are identified and controlled in the European Union.
CONTINUE READING ON www.edc-free-europe.org
2013 © MyChemicalMonitoring. ALL Rights Reserved. About Us | Terms and Conditions